Akt Signals through the Mammalian Target of Rapamycin Pathway to Regulate CNS Myelination
Top Cited Papers
Open Access
- 27 May 2009
- journal article
- Published by Society for Neuroscience in Journal of Neuroscience
- Vol. 29 (21) , 6860-6870
- https://doi.org/10.1523/jneurosci.0232-09.2009
Abstract
Mammalian target of rapamycin (mTOR), a well known Akt substrate, regulates multiple cellular functions including cell growth and protein synthesis. The current study identifies a novel role of the Akt/mTOR pathway as a regulator of CNS myelination. Previously, we showed that overexpressing constitutively active Akt in oligodendrocytes in a transgenic mouse model induces enhanced CNS myelination, with no changes in the proliferation or survival of oligodendrocyte progenitor or mature cells. The present study focused on the signaling mechanisms regulating this hypermyelination induced by Akt. Activation of mTOR and its downstream substrates (p70S6 kinase and S6 ribosomal protein) was observed in Akt-overexpressing oligodendrocytes. When mTOR signaling was inhibited chronically in vivo with rapamycin starting at 6 weeks of age, the observed hypermyelination was reduced to approximately the amount of myelin seen in wild-type mice. mTOR inhibition had little impact on wild-type myelination between 6 and 12 weeks of age, suggesting that, in normal adults, myelination is relatively complete and is no longer regulated by mTOR signaling. However, when mTOR was chronically inhibited in young adult wild-type mice, myelination was reduced. These results suggest that, during active myelination, the major Akt signal regulating CNS myelination is the mTOR pathway.Keywords
This publication has 50 references indexed in Scilit:
- Activation of the Mammalian Target of Rapamycin (mTOR) Is Essential for Oligodendrocyte DifferentiationJournal of Neuroscience, 2009
- Rapamycin differentially inhibits S6Ks and 4E-BP1 to mediate cell-type-specific repression of mRNA translationProceedings of the National Academy of Sciences, 2008
- Constitutively active Akt1 expression in mouse pancreas requires S6 kinase 1 for insulinoma formationJournal of Clinical Investigation, 2008
- S6K1 Plays a Key Role in Glial TransformationCancer Research, 2008
- Production, characterization, and efficient transfection of highly pure oligodendrocyte precursor cultures from mouse embryonic neural progenitorsGlia, 2008
- Response of a Neuronal Model of Tuberous Sclerosis to Mammalian Target of Rapamycin (mTOR) Inhibitors: Effects on mTORC1 and Akt Signaling Lead to Improved Survival and FunctionJournal of Neuroscience, 2008
- The mTOR Pathway as a Potential Target for the Development of Therapies Against Neurological DiseaseDrug News & Perspectives, 2007
- Induction of oligodendrocyte differentiation by Olig2 and Sox10: Evidence for reciprocal interactions and dosage-dependent mechanismsDevelopmental Biology, 2006
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitiveNature Cell Biology, 2004